Discover how Trump’s healthcare picks could reshape U.S. biopharma and drive major changes in the healthcare policy.

Discover various promising treatments in development to address the unmet needs of people with Charcot–Marie–Tooth disease.

Delve into the field of miRNA with 7 promising companies with miRNA-focused candidates in the pipeline, from oncology to ...

Labiotech provides listing of 2025 biotech conferences and events purely as a service for readers. We are not responsible for ...

Discover how ADCs are advancing oncology, the regulatory challenges they face, and the promise they hold for the future of ...

As the signs point toward a potential Evotec acquisition, delve into what it could represent for the European biotech ...

Find out how Google DeepMind's AlphaFold3 platform could help scientists revolutionize the field of drug discovery.

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

The hypoparathyroidism treatment space has made a buzz in 2024 with a major drug approval, acquisitions, and big advances in ...

Advanced therapy medicinal products (ATMPs) are pushing the boundaries of medicine, offering hope for previously untreatable ...

Antisense oligonucleotides are essentially short, single-stranded synthetic fragments of DNA or RNA that bind specifically to the target RNA sequence inside cells and modulate protein expression ...